The United States has removed Venezuela from its list of countries that “failed demonstrably” to meet international counternarcotics obligations.

The change marks a major shift in U.S. drug policy toward Venezuela. Reuters reported that Venezuela had remained on the failed list since 2005.

The Trump administration announced the change as part of the 2027 annual drug certification process. Venezuela still appears on the broader list of major drug-transit or drug-producing countries.

Colombia remains on the “failed demonstrably” list. Trump said he could consider removing Colombia if the country makes progress against coca production and narcoterrorist groups.

What Changed for Venezuela?

The United States uses more than one category when it evaluates international drug trafficking.

The first category covers countries that the U.S. considers major drug producers or transit countries.

The second category covers countries that the U.S. says have “failed demonstrably” to meet their counternarcotics commitments.

Venezuela remains in the first category.

However, the Trump administration removed Venezuela from the second category.

This difference matters when reading headlines about the US drug list Venezuela decision.

The move does not mean that Washington has removed Venezuela from all drug-trafficking assessments.

It means that the U.S. changed Venezuela’s status under the separate “failed demonstrably” determination. Reuters confirmed that Venezuela remains a major drug-transit or production country under the broader U.S. assessment.

Why Did the U.S. Remove Venezuela From the Drug List?

The Trump administration linked the decision to increased cooperation from Venezuela’s interim government.

Reuters reported that Trump cited cooperation with interim President Delcy Rodríguez. He also pointed to actions against criminal organizations, including the killing of Tren de Aragua leader Héctor Guerrero Flores, known as “Niño Guerrero.”

Trump also said he expects Venezuela to keep making measurable progress.

The administration therefore tied Venezuela’s new status to its assessment of counternarcotics cooperation.

The change also comes after major political changes in Venezuela earlier this year.

Venezuela had remained on the failed list for more than two decades. The new determination removes that specific designation for 2027.

Venezuela Is Still on the Major Drug List

Venezuela has not disappeared from the U.S. counternarcotics framework.

The country remains on the broader list of major drug-transit or major illicit drug-producing countries.

Reuters reported that Venezuela and Colombia both remain on that broader list. Other countries include Mexico, Peru, Bolivia, Afghanistan and several countries across Latin America and Asia.

This creates an important distinction.

Venezuela is no longer classified as “failed demonstrably.”

Venezuela is still classified as a major drug-transit or drug-producing country.

Those two statements can both be true.

That distinction should help readers understand the latest Venezuela drug list news without confusing the two U.S. classifications.

Colombia Remains on the Failed List

Colombia remains on the U.S. “failed demonstrably” list for 2027.

Trump said Colombia could leave the list if it makes progress against coca cultivation and narcoterrorist networks.

The issue has become an important part of U.S.-Colombia security relations.

Reuters has reported on closer security cooperation between Washington and Colombia under the country’s new government.

For readers following Colombia drug certification, the next annual determination will therefore matter.

It could show whether the U.S. changes Colombia’s status after reviewing its progress.

What Does “Failed Demonstrably” Mean?

“Failed demonstrably” refers to a specific U.S. government determination.

It does not simply mean that a country has drug trafficking problems.

The designation concerns a country’s efforts to meet international counternarcotics obligations.

The U.S. reviews these efforts as part of its annual certification process.

That process helps Washington determine how it classifies countries involved in international drug production and trafficking.

For Venezuela, the Trump administration now says the country should no longer receive the failed designation for 2027.

For Colombia, the administration has kept the designation in place.

Why Is Venezuela Still on the Broader List?

The broader list focuses on countries that the U.S. considers major locations for drug production or transit.

A country can appear on that list without receiving the “failed demonstrably” designation.

This explains Venezuela’s current position.

The country remains a major drug-transit or production country in the U.S. assessment.

At the same time, the Trump administration says Venezuela has made enough progress to avoid the separate failed designation for 2027.

Could Colombia Leave the List?

Trump said he may consider removing Colombia from the failed designation if the country makes progress.

He specifically mentioned coca eradication and action against narcoterrorist networks.

That means Colombia’s status could change in a future U.S. determination.

The next assessment will depend on the administration’s review of Colombia’s counternarcotics efforts.

For now, Colombia remains on the failed list.

What Does This Mean for U.S. Drug Policy?

The Venezuela decision shows the difference between two U.S. assessments.

One assessment identifies major drug-producing and drug-transit countries.

The other evaluates whether countries have made sufficient efforts to meet counternarcotics commitments.

Venezuela currently falls into the first category but not the second.

Colombia remains in both broader drug-trafficking assessments and the “failed demonstrably” category.

This distinction gives readers a clearer picture of the latest U.S. counternarcotics policy in Latin America.

Frequently Asked Questions

Why did the U.S. remove Venezuela from the drug list?

The Trump administration cited increased cooperation from Venezuela’s interim government.

Trump also pointed to actions against drug-trafficking organizations. Reuters reported that these developments helped support the decision.

Is Venezuela completely removed from the U.S. drug list?

No.

Venezuela remains on the broader list of major drug-transit or drug-producing countries.

The change only concerns the separate “failed demonstrably” designation.

Is Colombia still on the failed list?

Yes.

Colombia remains on the “failed demonstrably” list for 2027.

Trump said he could consider removing the designation if Colombia makes progress against coca production and narcoterrorist networks.

What is the “failed demonstrably” list?

It is a U.S. government classification for countries that the administration says failed to meet international counternarcotics commitments.

It is separate from the broader list of major drug-producing and drug-transit countries.

What happens next?

The U.S. will continue to monitor counternarcotics efforts in Venezuela and Colombia.

Future annual determinations can change the status of individual countries.

Final Takeaway

The latest US drug list Venezuela decision does not remove Venezuela from every U.S. drug-trafficking assessment.

Instead, the Trump administration removed Venezuela from the “failed demonstrably” category for 2027.

Venezuela remains on the broader list of major drug-transit or drug-producing countries.

Colombia remains on the failed list.

Trump said Colombia could receive a different status if it makes progress against coca cultivation and narcoterrorist networks.

The key point is simple: Venezuela’s classification changed, but the U.S. still considers the country relevant to international drug trafficking.